UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study

Journal of diabetes investigation, 2020-09, Vol.11 (5), p.1248-1257

2020

Volltextzugriff (PDF)

A Prospective Intervention Study on the Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes in Kanagawa

Journal of the Japan Diabetes Society, 2019/10/30, Vol.62(10), pp.649-658

2019

Volltextzugriff (PDF)

Cross‐sectional survey of diabetic neuropathy in Kanagawa and clinical significance of a touch test using tissue paper

Journal of diabetes investigation, 2012-06, Vol.3 (3), p.252-258

2012

Volltextzugriff (PDF)

The safety, efficacy and predictors for HbA1c reduction of sitagliptin in the treatment of Japanese type 2 diabetes

Diabetes research and clinical practice, 2012-01, Vol.95 (1), p.e20-e22

2012

Volltextzugriff (PDF)

Effects of sitagliptin on the serum creatinine in Japanese type 2 diabetes

Diabetes research and clinical practice, 2015-06, Vol.108 (3), p.e42-e45

2015

Volltextzugriff (PDF)

Sitagliptin Versus Ipragliflozin for Type 2 Diabetes in Clinical Practice

Journal of endocrinology and metabolism, 2019-10, Vol.9 (5), p.151-158

2019

Volltextzugriff (PDF)

Safety and efficacy of adding sitagliptin to insulin in patients with type 2 diabetes: The ASSIST-K study

Diabetes research and clinical practice, 2014-03, Vol.103 (3), p.e30-e33

2014

Volltextzugriff (PDF)

Efficacy and Safety of Ipragliflozin in Patients With Type 2 Diabetes: ASSIGN-K Study

Journal of endocrinology and metabolism, 2019-06, Vol.9 (3), p.51-62

2019

Volltextzugriff (PDF)

日本人2型糖尿病患者に対するイプラグリフロジン投与52週間の有効性と安全性に関する前向き介入研究

糖尿病, 2019/10/30, Vol.62(10), pp.649-658

2019

Volltextzugriff (PDF)

Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes Mellitus

Journal of clinical medicine research, 2017-07, Vol.9 (7), p.586-595

2017

Volltextzugriff (PDF)

Factors Influencing Changes in Hemoglobin A1c and Body Weight During Treatment of Type 2 Diabetes With Ipragliflozin: Interim Analysis of the ASSIGN-K Study

Journal of clinical medicine research, 2016-05, Vol.8 (5), p.373-378

2016

Volltextzugriff (PDF)

Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study

Journal of clinical medicine research, 2016-02, Vol.8 (2), p.116-125

2016

Volltextzugriff (PDF)

Pleiotropic effects of sitagliptin in the treatment of type 2 diabetes mellitus patients

Journal of clinical medicine research, 2012-10, Vol.4 (5), p.309-313

2012

Volltextzugriff (PDF)

The Pathogenesis of CPK Elevation in Severe Acute Diabetic Syndrome

Journal of the Japan Diabetes Society, 1988/04/30, Vol.31(4), pp.277-283

1988

Volltextzugriff (PDF)

Effects of somatostatin deficiency on cell distribution within the Langerhans islets

Diabetes research and clinical practice, 1985, Vol.1 (6), p.335-342

1985

Volltextzugriff (PDF)

Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2

Journal of antibiotics, 2013-09, Vol.66 (9), p.543-548

2013

Volltextzugriff (PDF)

Mitochondrial complex I inhibitors suppress tumor growth through concomitant acidification of the intra- and extracellular environment

iScience, 2021-12, Vol.24 (12), p.103497-103497, Article 103497

2021

Volltextzugriff (PDF)

Abstract A171: Antitumor effects of intervenolin, a novel natural compound with anti-Helicobacter pylori activity, and its synthetic derivatives on gastric and colorectal cancer cells

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.A171-A171

2013

Volltextzugriff (PDF)

Investigation of FOLFIRI/FOLFOX (+/-bevacizumab) therapy for patients with metastatic colorectal cancer in our hospital

Gan to kagaku ryoho, 2010-05, Vol.37 (5), p.841

2010

Volltextzugriff (PDF)

Transmenteric Hiatus Hernia in the Mesentery of a Transverse Colon

The Japanese Journal of Gastroenterological Surgery, 2011/12/01, Vol.44(12), pp.1591-1596

2011

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(40)

Sprache

Englisch
(31)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Life Sciences & Biomedicine
(13)
Humans
(10)
Original
(9)
Endocrinology & Metabolism
(8)
Female
(7)
Middle Aged
(7)
Aged
(6)
Male
(6)
Sitagliptin
(5)
Adult
(4)
Dipeptidyl Peptidase-4 Inhibitor
(4)
Animals
(3)
Biological And Medical Sciences
(3)
Cardiac & Cardiovascular Systems
(3)
Cardiovascular System & Cardiology
(3)
Diabetes Mellitus, Type 2 - Drug Therapy
(3)
General Medicine
(3)
Ipragliflozin
(3)
Medical Sciences
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study

A Prospective Intervention Study on the Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes in Kanagawa

Cross‐sectional survey of diabetic neuropathy in Kanagawa and clinical significance of a touch test using tissue paper

The safety, efficacy and predictors for HbA1c reduction of sitagliptin in the treatment of Japanese type 2 diabetes

Effects of sitagliptin on the serum creatinine in Japanese type 2 diabetes

Sitagliptin Versus Ipragliflozin for Type 2 Diabetes in Clinical Practice

Safety and efficacy of adding sitagliptin to insulin in patients with type 2 diabetes: The ASSIST-K study

Efficacy and Safety of Adding Sitagliptin in Type 2 Diabetes Patients on Insulin: Age-Stratified Comparison at One Year in the ASSIST-K Study

Efficacy and Safety of Ipragliflozin in Patients With Type 2 Diabetes: ASSIGN-K Study

Add-On Sitagliptin Therapy for Insulin-Treated Type 2 Diabetes: An Analysis of Hemoglobin A1c and Other Variables Using ASSIST-K Follow-Up Data

日本人2型糖尿病患者に対するイプラグリフロジン投与52週間の有効性と安全性に関する前向き介入研究

Effectiveness of Ipragliflozin for Reducing Hemoglobin A1c in Patients With a Shorter Type 2 Diabetes Duration: Interim Report of the ASSIGN-K Study

Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes Mellitus

Factors Influencing Changes in Hemoglobin A1c and Body Weight During Treatment of Type 2 Diabetes With Ipragliflozin: Interim Analysis of the ASSIGN-K Study

Correction: Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study

Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study

Factors Predicting Therapeutic Efficacy of Combination Treatment With Sitagliptin and Insulin in Type 2 Diabetic Patients: The ASSIST-K Study

Pleiotropic effects of sitagliptin in the treatment of type 2 diabetes mellitus patients

The Pathogenesis of CPK Elevation in Severe Acute Diabetic Syndrome

Effects of somatostatin deficiency on cell distribution within the Langerhans islets

Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2

Mitochondrial complex I inhibitors suppress tumor growth through concomitant acidification of the intra- and extracellular environment

Abstract A171: Antitumor effects of intervenolin, a novel natural compound with anti-Helicobacter pylori activity, and its synthetic derivatives on gastric and colorectal cancer cells

Investigation of FOLFIRI/FOLFOX (+/-bevacizumab) therapy for patients with metastatic colorectal cancer in our hospital

Transmenteric Hiatus Hernia in the Mesentery of a Transverse Colon

Suchergebnisse filtern